CUBE vs STRO
CubeSmart (CUBE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CUBE and STRO stock pages for the full models.
Not investment advice.